8-KThe WireRoutine
Reg FD Disclosure
Filed Nov 22, 2021 · 4y ago · Accession 0001193125-21-336045
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRISPR Therapeutics AG
- Ticker
- CRSP
- CIK
- 1674416
- Form type
- 8-K
- Filing date
- Nov 22, 2021
- Report date
- Nov 22, 2021
- Document
- d268217d8k.htm
- Size
- 154 KB